New study aims to predict bleeding in liver patients during routine procedures

NCT ID NCT07405749

Not yet recruiting Knowledge-focused Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will follow 2,500 patients with liver cirrhosis or portal hypertension who are scheduled for elective medical procedures. Researchers want to find out how often bleeding happens and what factors predict it, beyond standard blood tests. The goal is to improve safety by focusing on procedure type and patient condition rather than just lab numbers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better guidelines for safely performing elective procedures in patients with liver disease and portal hypertension.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly change patient care. Results may not apply to all patients or procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver esophageal varices portal hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CIRRHOSIS, LIVER CLINICALLY SIGNIFICANT PORTAL HYPERTENSION(CSPH) GASTROESOPHAGEAL VARICES PORTAL HYPERTENSION

Contacts and locations

Locations

Fondazione Policlinico Universitaro A. Gemelli IRCSS,UOC Medicina Interna e Gastroenterologia,Largo A. Gemelli,

Roma, 00168, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.